Physician profile
Sameet Palkhiwala
NPI 1013053461
$1,989.46
in general payments reported to CMS, 2019-2025
15 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $353 · 2021: $34.00 · 2022: $150 · 2023: $559 · 2024: $198 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $634.47 | 2023-2025 | Avvigo Guidance System, Rotapro, Stingray |
| Abbott Laboratories | $365.02 | 2019-2024 | Optis |
| Shockwave Medical, INC | $199.00 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $167.25 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.38 | 2019 | |
| Amarin Pharma, INC. | $152.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $95.19 | 2019-2020 | |
| Novo Nordisk INC | $54.47 | 2021-2022 | |
| Astellas Pharma US INC | $37.25 | 2019-2020 | |
| Amgen INC. | $30.50 | 2019 | |
| Philips North America LLC | $25.42 | 2025 | Ecc Solutions |
| Lilly USA, LLC | $21.05 | 2019 | |
| Pfizer INC. | $17.96 | 2023 | |
| Glaxosmithkline, LLC. | $16.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameet Palkhiwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.